image
Assertio Holdings, Inc. ASRT
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 0.61
0.378 %
$ 58.4 M
Market Cap
-2.65
P/E
CASH FLOW STATEMENT
26.4 M OPERATING CASH FLOW
-46.76%
Growth Rates
1Year -46.76%
3Years 68.47%
5Years -21.83%
7Years -11.51%
10Years 9.47%
-48.9 M INVESTING CASH FLOW
-1579.30%
Growth Rates
1Year -1579.30%
3Years -38.21%
5Years -101.27%
7Years -9.14%
10Years -0.33%
-350 K FINANCING CASH FLOW
99.21%
Growth Rates
1Year 99.21%
3Years -0.40%
5Years 70.54%
7Years 56.07%
10Years -0.01%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Assertio Holdings, Inc.
image
120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -21.6 M
Depreciation & Amortization 25.8 M
Capital Expenditures 0
Stock-Based Compensation 5.01 M
Change in Working Capital 5.2 M
Others 34.4 M
Free Cash Flow 26.4 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
OPERATING CASH FLOW
Net Income (21.6) (331.9) 109.6 (1.3) (28.1) (217.2) 36.9 (102.5) (88.7) (75.7) (111.0) 25.2 (29.8) 70.7 3.9 (22.0) (15.3) 49.2 (39.7) (24.5) (26.9) (30.0) (13.5) (17.6) (9.7) (17.2) (2.8) (1.2) (0.5)
Depreciation & Amortization 25.8 28.2 33.4 29.1 26.4 102.9 106.4 105.5 109.4 85.7 12.0 6.2 2.6 0.4 0.4 0.8 1.1 0.9 1.4 1.1 1.7 1.0 0.7 0.6 0.6 0.6 0.5 0.2 0
Deferred Income Tax 0 76.2 (80.4) 1.4 (8.4) (5.8) 1.3 (8.7) 20.3 (44.2) 87.4 (103.2) 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 5.0 9.2 7.5 3.5 10.9 10.6 12.6 13.0 17.2 14.2 8.9 6.1 5.1 3.9 2.0 2.7 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 11.9 267.8 21.5 4.1 (22.1) 200.5 22.5 36.5 24.5 34.0 18.8 6.4 0.3 0 0 0 2.5 2.3 2.6 (0.2) 1.0 0.8 3.0 3.5 2.3 12.0 100 K 0 100 K
Change in Working Capital 5.2 0.1 (13.0) (31.3) (44.2) (0.6) (107.2) 18.3 (17.1) 129.8 (72.0) 69.1 (9.7) (17.4) (8.7) 20.4 15.1 (37.8) 8.0 52.3 0.9 (5.0) 5.3 1.1 0.1 0.6 (0.3) 100 K 0
Cash From Operations 26.4 49.6 78.6 5.5 (65.6) 90.5 72.5 62.2 65.5 143.9 (55.9) 9.8 (31.0) 57.7 (2.4) 1.8 3.4 14.7 (27.7) 28.8 (23.3) (33.1) (4.4) (12.4) (6.7) (3.9) (2.5) (1.1) (0.4)
INVESTING CASH FLOW
Capital Expenditures 0 (0.6) (0.3) 53 K 10 K (1.5) (5.5) (0.7) (2.9) (26.7) (0.6) (2.0) (6.9) (0.7) (0.2) (0.6) (0.3) (0.2) (0.8) (0.8) (2.7) (1.1) (0.5) (1.3) (0.9) (0.1) (0.9) 100 K 0
Other Items (48.9) 3.7 (42.4) (18.5) 512.8 0 (1.6) 58.6 48.4 (1 081.3) (46.7) (36.1) 40.2 (61.5) 0.7 4.8 (4.9) (35.8) 32.5 (34.0) 6.8 (15.6) (12.0) (0.4) (12.5) 1.0 (4.6) 0 100 K
Cash From Investing Activities (48.9) 3.1 (42.7) (18.5) 512.8 (1.5) (7.1) 57.9 45.5 (1 108.1) (47.3) (38.0) 33.3 (62.2) 0.5 4.1 (5.1) (36.0) 31.8 (34.8) 4.1 (16.7) (12.4) (1.7) (13.4) 0.9 (5.5) 100 K 100 K
FINANCING CASH FLOW
Common Stock Repurchased (0.3) (7.9) (0.8) (0.4) (0.9) (0.6) (0.7) (0.8) (3.3) (2.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 (10.5) (4.8) (9.8) (454.3) (153.2) (82.5) (110.0) (100.0) 562.1 345.0 0 0 (2.2) (3.8) (3.3) 9.1 0 0 (9.8) (0.3) (0.4) 2.7 4.1 1.3 69.6 K 0.4 (0.3) 100 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.3) (25.8) (9.1) (5.6) (13.5) (4.3) (0.2) (9.1) (6.8) (1.6) (7.6) 240.2 0 0 0 0 0 21.1 446 0 0 0 0 0 0 0 0 0 100 K
Cash From Financing Activities (0.3) (44.2) (7.8) 29.0 (468.6) (157.8) (81.3) (110.9) (94.4) 576.6 347.2 243.9 2.7 6.1 (2.4) (1.3) 9.5 21.1 2.9 12.6 91.2 K 58.4 23.3 15.4 23.0 64.6 K 7.9 5.3 100 K
CHANGE IN CASH
Net Change In Cash (22.9) 8.5 28.1 16.0 (21.3) (68.8) (15.9) 9.2 16.6 (387.6) 244.0 215.6 5.0 1.5 (4.3) 4.7 7.8 (0.2) 7.0 6.6 (19.1) 8.5 6.4 1.3 2.9 (3.1) 7.9 5.3 (0.4)
FREE CASH FLOW
Free Cash Flow 26.4 49.0 78.3 5.5 (65.6) 89.0 67.0 61.5 62.6 117.2 (56.5) 7.8 (37.9) 57.0 (2.6) 1.2 3.1 14.5 (28.5) 28.0 (25.9) (34.3) (4.9) (13.7) (7.6) (4.1) (3.4) (1.2) (0.4)